<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34351890</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1665-1146</ISSN><JournalIssue CitedMedium="Internet"><Volume>78</Volume><Issue>4</Issue><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Boletin medico del Hospital Infantil de Mexico</Title><ISOAbbreviation>Bol Med Hosp Infant Mex</ISOAbbreviation></Journal><ArticleTitle>[Respiratory aspects and pulmonary physiotherapy in the child with mucopolysaccharidosis].</ArticleTitle><Pagination><StartPage>318</StartPage><EndPage>325</EndPage><MedlinePgn>318-325</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.24875/BMHIM.20000266</ELocationID><Abstract><AbstractText>La mucopolisacaridosis es un grupo heterog&#xe9;neo de enfermedades que se caracterizan por la acumulaci&#xf3;n lisosomal de sustancias intermedias del metabolismo de los mucopolisac&#xe1;ridos o glucosaminoglucanos. El trastorno respiratorio que caracteriza a los pacientes con mucopolisacaridosis es la enfermedad pulmonar restrictiva cr&#xf3;nica, por lo que la rehabilitaci&#xf3;n pulmonar, cuyo objetivo es mejorar los s&#xed;ntomas respiratorios, y la fisioterapia respiratoria, mejorar&#xe1;n la ventilaci&#xf3;n pulmonar y la biomec&#xe1;nica respiratoria deteriorada. Es necesario el seguimiento por el neum&#xf3;logo infantil, quien cuantificar&#xe1; la funci&#xf3;n pulmonar y vigilar&#xe1; los s&#xed;ntomas de obstrucci&#xf3;n nocturna y de restricci&#xf3;n pulmonar con ayuda de estudios como la espirometr&#xed;a, la pletismograf&#xed;a y la prueba de la caminata de 6 minutos, por mencionar algunas. Tambi&#xe9;n es muy importante realizar un programa individualizado de t&#xe9;cnicas de fisioterapia respiratoria y de ejercicios. Todo lo anterior, con el objetivo de evaluar la funci&#xf3;n pulmonar como un marcador de respuesta al uso de cualquiera de las terapias indicadas en la mucopolisacaridosis. Mucopolysaccharidosis is a heterogeneous group of diseases characterized by the lysosomal accumulation of intermediates in the metabolism of mucopolysaccharides or glycosaminoglycans. The respiratory disorder that characterizes patients with mucopolysaccharidosis is the chronic restrictive lung disease. Therefore, pulmonary rehabilitation aimed at improving respiratory symptoms and respiratory physiotherapy will improve pulmonary ventilation and impaired respiratory biomechanics in patients with mucopolysaccharidosis. Follow-up by the pediatric pulmonologist is necessary to quantify lung function and monitor the symptoms of nocturnal obstruction and pulmonary restriction with the help of studies such as spirometry, plethysmography and the 6-minute walk test, among others. It is also very important to perform an individualized program of respiratory physiotherapy techniques and exercises. Overall, all of these steps are followed for evaluating lung function as a marker of response to the use of any of the therapies indicated in mucopolysaccharidosis.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2021 Permanyer.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cruz-Anleu</LastName><ForeName>Israel D</ForeName><Initials>ID</Initials><AffiliationInfo><Affiliation>Servicio Cl&#xed;nico de Neumolog&#xed;a Pedi&#xe1;trica, Centro Regional de Alta Especialidad, Hospital de Especialidades Pedi&#xe1;tricas Tuxtla Guti&#xe9;rrez, Tuxtla Guti&#xe9;rrez, Chiapas, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sol&#xed;s-Trujeque</LastName><ForeName>Marvin V</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Servicio Cl&#xed;nico de Neumolog&#xed;a Pedi&#xe1;trica, Centro Regional de Alta Especialidad, Hospital de Especialidades Pedi&#xe1;tricas Tuxtla Guti&#xe9;rrez, Tuxtla Guti&#xe9;rrez, Chiapas, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pe&#xf1;a-Hern&#xe1;ndez</LastName><ForeName>Beth Sainz De La</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Servicio Cl&#xed;nico de Neumolog&#xed;a Pedi&#xe1;trica, Centro Regional de Alta Especialidad, Hospital de Especialidades Pedi&#xe1;tricas Tuxtla Guti&#xe9;rrez, Tuxtla Guti&#xe9;rrez, Chiapas, M&#xe9;xico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Aspectos respiratorios y de fisioterapia pulmonar en el ni&#xf1;o con mucopolisacaridosis.</VernacularTitle></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Bol Med Hosp Infant Mex</MedlineTA><NlmUniqueID>0414106</NlmUniqueID><ISSNLinking>0539-6115</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009083" MajorTopicYN="Y">Mucopolysaccharidoses</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D026741" MajorTopicYN="N">Physical Therapy Modalities</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Fisioterapia respiratoria</Keyword><Keyword MajorTopicYN="N">Funci&#xf3;n pulmonar</Keyword><Keyword MajorTopicYN="N">Mucopolisacaridosis</Keyword><Keyword MajorTopicYN="N">Mucopolysaccharidosis</Keyword><Keyword MajorTopicYN="N">Pulmonary function</Keyword><Keyword MajorTopicYN="N">Pulmonary physiotherapy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>5</Day><Hour>17</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34351890</ArticleId><ArticleId IdType="doi">10.24875/BMHIM.20000266</ArticleId><ArticleId IdType="pii">j78/4/318</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>